Phase III study of the eastern cooperative oncology group (ECOG 2597): Induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer Article

Belani, CP, Wang, W, Johnson, DH et al. (2005). Phase III study of the eastern cooperative oncology group (ECOG 2597): Induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer . JOURNAL OF CLINICAL ONCOLOGY, 23(16), 3760-3767. 10.1200/JCO.2005.09.108

cited authors

  • Belani, CP; Wang, W; Johnson, DH; Wagner, H; Schiller, J; Veeder, M; Mehta, M

sustainable development goals

authors

publication date

  • June 1, 2005

webpage

published in

keywords

  • CARCINOMA
  • DOSE-ESCALATION
  • Life Sciences & Biomedicine
  • Oncology
  • RADIATION-THERAPY
  • SURVIVAL
  • Science & Technology
  • TRIAL

Location

  • Chicago, IL

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 3760

end page

  • 3767

volume

  • 23

issue

  • 16